摘要
Abstract
Objective To analyze the clinical effect of Xinyi Biyan Wan combined with budesonide in the treatment of allergic rhinitis. Methods 112 patients with allergic rhinitis admitted to our hospital were randomly divided into control group and observation group, 56 cases each. The control group was treated with budesonide. The observation group was treated with Xinyi Biyan Wan. The clinical efficacy, serum IgE level, LTE4 content and adverse drug reactions were compared between the two groups.Results The total effective rate of the observation group was 85.71％, which was higher than that of the control group 75.00％, the difference was statistically significant (P＜0.05) .In the 4 weeks of treatment, the serum LTE4 content and IgE level of the observation group were lower than those of the control group, the difference was statistically significant (P＜0.05) . The incidence of adverse reactions in the observation group was 5.36％, which was lower than that in the control group (12.50％) , but the difference was not statistically significant (P＞0.05) .Conclusion The clinical effect of Xinyi Biyan Wan combined with budesonide in the treatment of allergic rhinitis is significant, which can improve the serum IgE level and LTE4 content, and the safety is better.关键词
辛夷鼻炎丸/布地奈德/变应性鼻炎/IgE/LTE4Key words
Xinyi Biyan Wan/Budesonide/Allergic rhinitis/IgE/LTE4分类
医药卫生
